MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Immunosuppression"

  • 2026 International Congress

    Movement Disorders Associated with Infections in Immunocompromised Non-HIV Patients: A Systematic Review

    J. Sánchez-León, M. Parra Alvarez, I. Da-Silva-Gomes, T. Schlickmann, T. Luise Denicol, C. Matte Dagostini, D. Teixeira-Dos-Santos, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To identify the most frequent movement disorders and their clinical features, as well as the most common infectious etiologies in immunocompromised non-HIV patients, based…
  • 2026 International Congress

    Immunological characteristics of Parkinson’s disease by clinical form and stage

    S. Jumanazarova, E. Abduqodirov, R. Matmurodov, S. Mamatova (Tashkent, Uzbekistan)

    Objective: To analysed of IL-10 concentrations in serum of patients with PD. Background: IL-10 is a key pro-inflammatory cytokine involved in the regulation of microglia…
  • 2026 International Congress

    Immunological principles of levodopa therapy in Parkinson’s disease

    N. Naimov, B. Muminov, S. Jumanazarova, R. Matmurodov, H. Daminova (Tashkent, Uzbekistan)

    Objective: Study of the relationship between serum IL-10 levels in patients with Parkinson's disease and levodopa therapy Background: In Parkinson's disease, dehydroepiandrosterone can lead to…
  • 2026 International Congress

    Levels of cytokines in the cerebrospinal fluid of patients depending on the stages of Parkinson’s disease

    B. Amonov, B. Muminov, E. Abduqodirov, R. Matmurodov, S. Jumanazarova (Tashkent, Uzbekistan)

    Objective: To study of cytokine levels in serum and cerebrospinal fluid of patients with different stages of PD. Background: The clinical course of Parkinson's disease…
  • 2026 International Congress

    Azathioprine-associated changes in peripheral–central immune signalling in Parkinson’s disease: post-hoc analysis of AZA-PD

    J. Greenland, J. Holbrook, R. Pal, L. Kahanawita, K. Dresser, E. Cutting, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To assess whether changes in peripheral markers of CNS immune cell trafficking relate to clinical response to azathioprine in AZA-PD Background: We conducted a…
  • 2026 International Congress

    Role and significance of C-reactive protein in stages of Parkinson’s disease

    R. Matmurodov, S. Jumanazarova, H. Daminova, K. Khalimova (Tashkent, Uzbekistan)

    Objective: To сomparative analysis of the amount of CRP in the blood serum of patients according to the stages of PD. Background: C-reactive protein (CRP)…
  • 2026 International Congress

    Levels of IgA and IgG concentrations by stage of Parkinson’s disease

    S. Jumaniyozov, R. Matmurodov, H. Daminova, S. Inoyatova (Tashkent, Uzbekistan)

    Objective: To study of IgA and IgG levels cerebrospinal fluid of patients with different stages of PD. Background: In the clinical course of Parkinson's disease…
  • 2025 International Congress

    Hyperkinetic Movement Disorder associated with Papillary Thyroid Carcinoma

    U. Agarwal, R. Al-Hader, S. Fu, Z. Farzal, M. Cerghet (Detroit, USA)

    Objective: To describe a case of hyperkinetic movement disorder associated with papillary thyroid carcinoma, highlighting the diagnostic workup and therapeutic interventions. Background: Paraneoplastic neurological syndromes…
  • 2025 International Congress

    A Rare Case of Anti-Hu Opsoclonus-Myoclonus Syndrome after Immune Checkpoint Inhibitor Immunotherapy in a Patient with Small Cell Lung Cancer in Remission

    L. Hong, P. Atit, R. Patil, E. Sandberg, A. Makarova (Tampa, USA)

    Objective: To describe a case of anti-Hu/ANNA-1 Opsoclonus-Myoclonus syndrome (OMS) in a patient with small cell lung cancer (SCLC) after treatment with an immune checkpoint…
  • 2025 International Congress

    Subacute Severe Dystonia in a 19-month Old Boy. A Case of Pediatric Stiff Person Syndrome (SPS)

    MU. Huun, S. Wallace, SH. Nordstrand (Oslo, Norway)

    Objective: To report a rare case of anti-GAD associated encephalitis with pediatric Stiff Person Syndrome (SPS) highlighting the need for broad investigations and extensive treatment.…
  • 1
  • 2
  • 3
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley